Stay updated on Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.

Latest updates to the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page
- CheckyesterdayChange DetectedThe study record now indicates that results have been posted, with updates to outcome measures and adverse-event information. The history also reflects a new version and a change from “Results Submitted” to “Results Posted.”SummaryDifference0.4%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRecord history now shows the latest revision as v3.7.0, replacing the previous v3.6.6. This reflects a software update to the page rather than changes to study information.SummaryDifference0.0%

- Check29 days agoChange DetectedVersion 72 is now listed with a return date of 2026-08-31 and a QC status of Has Not Concluded. The update also adds new sections for Outcome Measures (Results) and Document Section to the study record history.SummaryDifference0.4%

- Check36 days agoChange DetectedThe page history shows a new revision, v3.6.6, replacing the previous v3.6.5, indicating a minor update to the page version in the history.SummaryDifference0.0%

- Check58 days agoChange DetectedVersion 3.6.5 was added on 2026-08-04. The update introduces Adverse Events and Outcome Measures (Results) and notes that Quality Control Review has not concluded, with related changes to Study Status and document sections.SummaryDifference0.4%

- Check72 days agoChange DetectedRevision: v3.6.4 is now displayed on the page, replacing the previous v3.6.3. This reflects a new build of the ClinicalTrials.gov interface without changing the study record content or user-facing functionality.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Pleural Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Pleural Mesothelioma Clinical Trial page.